Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States
Clinical trial NCT02857764 · COMPLETED
Trial details
- NCT number
- NCT02857764
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-02-15
- Primary completion
- 2017-06-30
- Enrollment
- 127690
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.